Quarterly Consolidated Statement Of Cash Flows

JCR Pharmaceuticals Co.,Ltd. - Filing #7604217

Concept 2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
As at
2020-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
11,817,000,000 JPY
11,156,000,000 JPY
Interest and dividends received
35,000,000 JPY
39,000,000 JPY
Interest paid
-45,000,000 JPY
-46,000,000 JPY
Net cash provided by (used in) operating activities
9,289,000,000 JPY
10,341,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-11,333,000,000 JPY
-4,780,000,000 JPY
Purchase of investment securities
JPY
-91,000,000 JPY
Other, net
-84,000,000 JPY
152,000,000 JPY
Net cash provided by (used in) investing activities
-3,250,000,000 JPY
-3,290,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
750,000,000 JPY
1,250,000,000 JPY
Repayments of long-term borrowings
-750,000,000 JPY
-650,000,000 JPY
Proceeds from issuance of bonds
JPY
500,000,000 JPY
Dividends paid
-2,169,000,000 JPY
-1,083,000,000 JPY
Other, net
JPY
1,000,000 JPY
Net cash provided by (used in) financing activities
-2,179,000,000 JPY
8,304,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
612,000,000 JPY
-22,000,000 JPY
Net increase (decrease) in cash and cash equivalents
4,472,000,000 JPY
15,332,000,000 JPY
Cash and cash equivalents
30,733,000,000 JPY
26,260,000,000 JPY
10,928,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.